KEMTA masterclass: Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
-
Masterclass
Using early Health Technology Assessment (HTA) to estimate the cost-effectiveness and support strategic decisions for innovative technologies
By: Sabine Grimm/Bram Ramaekers
Language: English
The masterclasses will take place via Teams of Zoom. You can register by sending an e-mail to: Irene.vrancken@mumc.nl.
KEMTA (Clinical Epidemiology & Medical Technology Assessment) of MUMC+ regularly organises masterclasses for employees interested in research methods. The masterclasses give short insights into a variety of topics, from the basics of setting up research to statistics and hot topics such as early HTA.
Also read
-
PhD defence Aljoscha Körber
" Technological Advances in Mass Spectrometry Imaging"17 Dec -
PhD defence Karlijn Demers
"Health-related physical fitness in patients with inflammatory bowel disease: bridging the gap to physical exercise-based interventions"17 Dec -
PhD defence Nadine Louise Blankvoort
" Modern Citizens, Unmodern Others: Epistemic and Everyday Governance of Difference in Dutch Migrant Integration Practices"17 Dec